BHARAT IMMUNOLOGICALS owns latest Real Value of 6.7525 per share. The recent price of the firm is 6.5. At this time the firm appears to be fairly valued. This module approximates value of BHARAT IMMUNOLOGICALS from examining the firm fundamentals such as Return On Asset of
(9.86)% and Price to Earning of 262.88X as well as evaluating its technical indicators and Probability Of Bankruptcy. In general, we favor to invest in undervalued equities and to trade away overvalued equities since at some future date instruments prices and their ongoing real values will grow together.
August 19, 2019
BHARAT IMMUNOLOGICALS is very risky asset. Calculation of real value of BHARAT IMMUNOLOGICALS is based on 2 months time horizon. Increasing BHARAT IMMUNOLOGICALS time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
|Horizon||30 Days Login to change|
BHARAT IMMUNOLOGICALS BIOLOG is rated third in price to sales category among related companies. It is number one stock in price to earning category among related companies reporting about 876.27 of Price to Earning per Price to Sales.
|Price to Sales ( times )|
|Price to Earning ( times )|